MAPK3 (P27361) variants and mutations
MAPK3 (also known as P27361) is a human protein-coding gene encoding a mitogen-activated protein kinase 3 protein. It works with ERK2 to transmit growth-factor and mitogen signals to transcriptional and cytoplasmic targets. Abnormal ERK activation is a hallmark of many RAS-MAPK-driven cancers and developmental syndromes. This analysis covers 729 MAPK3 variants and mutations. Of these, 75% have computational variant effect predictions. Disease context includes cancer, Noonan syndrome, and hypertrophic cardiomyopathy. Example MAPK3 variants include A2E, A2G, and A2V.
Variant analysis overview
- Gene: MAPK3
- Protein: P27361
- UniProt accession: P27361
- Organism: Homo sapiens
- Variants analyzed: 729
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 500 unspecified-consequence records; 26 frameshift variants; 88 missense variants; 95 synonymous variants; 8 stop-gained variants; 1 in-frame deletions; 1 in-frame insertions; 4 splice-region variants; 6 substitution
- Prediction scores: 549 variants have prediction scores (75% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: cancer, Noonan syndrome, hypertrophic cardiomyopathy, Costello syndrome, non-small cell lung carcinoma, tuberculosis, cardiofaciocutaneous syndrome, autoimmune disorder of central nervous system, obesity disorder, Epidermal Inclusion Cyst, sinusitis, overnutrition.
Protein structure and variant hotspots
- Protein features: 1 domains; 2 binding sites; 5 post-translational modification sites.
- Structural context: 485 variants have structural context.
- PTM context: 16 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable MAPK3 variants
Examples include A2E, A2G, A2V, A3E, A3G, A3T, A3V, A4E. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2E (p.Ala2Glu), gnomAD rs1186880470, REVEL 0.29, CADD 22.40
- A2G (p.Ala2Gly), gnomAD rs1186880470, REVEL 0.23, CADD 21.30
- A2V (p.Ala2Val), gnomAD rs1186880470, REVEL 0.23, CADD 19.60
- A3E (p.Ala3Glu), gnomAD rs1487093652, REVEL 0.22, CADD 20.40
- A3G (p.Ala3Gly), gnomAD rs1487093652, REVEL 0.16, CADD 22.80
- A3T (p.Ala3Thr), Ensembl rs2151048945, REVEL 0.10, CADD 16.70
- A3V (p.Ala3Val), gnomAD rs1487093652, REVEL 0.17, CADD 22.10
- A4E (p.Ala4Glu), gnomAD rs1271627688, REVEL 0.25, CADD 16.40
- A4G (p.Ala4Gly), gnomAD rs1271627688, REVEL 0.13, CADD 20.80
- A4V (p.Ala4Val), gnomAD rs1271627688, REVEL 0.18, CADD 19.10
- A5G (p.Ala5Gly), ExAC rs757216432, gnomAD rs757216432, REVEL 0.21, CADD 21.50
- A5V (p.Ala5Val), ExAC rs757216432, gnomAD rs757216432, REVEL 0.21, CADD 20.00
- A6G (p.Ala6Gly), gnomAD rs1203827432, REVEL 0.19, CADD 22.10
- A6T (p.Ala6Thr), ExAC rs753603085, TOPMed rs753603085, gnomAD rs753603085, REVEL 0.15, CADD 18.90
- Q7E (p.Gln7Glu), gnomAD rs1464704515, REVEL 0.17, CADD 12.00
- Q7L (p.Gln7Leu), gnomAD rs1267157456, REVEL 0.18, CADD 18.90
- Q7P (p.Gln7Pro), gnomAD rs1267157456, REVEL 0.18, CADD 18.20
- Q7R (p.Gln7Arg), cosmic curated COSV53771, gnomAD rs1267157456, REVEL 0.14, CADD 17.30
- G8R (p.Gly8Arg), TOPMed rs1275164140, gnomAD rs1275164140, REVEL 0.19, CADD 20.70
- G8W (p.Gly8Trp), TOPMed rs1275164140, gnomAD rs1275164140, REVEL 0.41, CADD 25.20
- G9A (p.Gly9Ala), 1000Genomes rs559183760, ExAC rs559183760, TOPMed rs559183760, gnomAD rs559183760, REVEL 0.24, CADD 16.40
- G9D (p.Gly9Asp), 1000Genomes rs559183760, ExAC rs559183760, TOPMed rs559183760, gnomAD rs559183760, REVEL 0.26, CADD 19.10
- G9V (p.Gly9Val), 1000Genomes rs559183760, ExAC rs559183760, TOPMed rs559183760, gnomAD rs559183760, REVEL 0.23, CADD 19.00
- G10E (p.Gly10Glu), Ensembl rs2151048882, REVEL 0.20, CADD 20.20
- G11A (p.Gly11Ala), TOPMed rs955881745, gnomAD rs955881745, NCI-TCGA Cosmic COSV5377, REVEL 0.14, CADD 16.30, Variant assessed as somatic; high impact.
- G11C (p.Gly11Cys), gnomAD rs2073036554, REVEL 0.34, CADD 23.00
- G11V (p.Gly11Val), cosmic curated COSV53772, TOPMed rs955881745, gnomAD rs955881745, REVEL 0.27, CADD 18.80
- G12W (p.Gly12Trp), ExAC rs767677001, gnomAD rs767677001, REVEL 0.27, CADD 23.30
- E13* (p.Glu13Ter), cosmic curated COSV53774, TOPMed rs1461921044, gnomAD rs1461921044, CADD 36.00
- E13A (p.Glu13Ala), TOPMed rs2073036224, gnomAD rs2073036224, REVEL 0.22, CADD 20.60
- E13D (p.Glu13Asp), NCI-TCGA TCGA novel, Ensembl rs1031507615, REVEL 0.17, CADD 17.10, Variant assessed as somatic; moderate impact.
- E13K (p.Glu13Lys), cosmic curated COSV53773, TOPMed rs1461921044, gnomAD rs1461921044, REVEL 0.24, CADD 21.20
- E13Q (p.Glu13Gln), TOPMed rs1461921044, gnomAD rs1461921044, REVEL 0.21, CADD 20.30
- P14H (p.Pro14His), ExAC rs759741789, gnomAD rs759741789, REVEL 0.29, CADD 23.70
- R15C (p.Arg15Cys), rs766922585, ClinGen CA8002982, ClinVar RCV000893252, 1000Genomes rs766922585, REVEL 0.34, CADD 22.60, Likely benign, not provided
- R16G (p.Arg16Gly), TOPMed rs1314762868, gnomAD rs1314762868, REVEL 0.16, CADD 16.40
- R16I (p.Arg16Ile), NCI-TCGA Cosmic COSV5377, cosmic curated COSV53777, REVEL 0.18, CADD 17.10, Variant assessed as somatic; moderate impact.
- T17I (p.Thr17Ile), TOPMed rs2073035911, gnomAD rs2073035911, REVEL 0.10, CADD 15.90
- E18D (p.Glu18Asp), TOPMed rs1452164335, gnomAD rs1452164335, REVEL 0.15, CADD 2.02
- E18G (p.Glu18Gly), cosmic curated COSV10502, Ensembl rs1596884873, REVEL 0.13, CADD 17.20
- E18Q (p.Glu18Gln), NCI-TCGA Cosmic COSV5377, cosmic curated COSV53773, Variant assessed as somatic; moderate impact.
- G19A (p.Gly19Ala), TOPMed rs1468414653, REVEL 0.28, CADD 19.00
- G19E (p.Gly19Glu), cosmic curated COSV10808, TOPMed rs1468414653, REVEL 0.28, CADD 21.20
- G19V (p.Gly19Val), TOPMed rs1468414653
- V20A (p.Val20Ala), gnomAD rs2073035624, REVEL 0.14, CADD 19.50
- V20F (p.Val20Phe), TOPMed rs2073035669, REVEL 0.19, CADD 19.60
- V20G (p.Val20Gly), gnomAD rs2073035624, REVEL 0.23, CADD 22.40
- V20I (p.Val20Ile), TOPMed rs2073035669, REVEL 0.13, CADD 18.20
- G21C (p.Gly21Cys), ExAC rs773609716, TOPMed rs773609716, gnomAD rs773609716, REVEL 0.14, CADD 22.30
- G21S (p.Gly21Ser), ExAC rs773609716, TOPMed rs773609716, gnomAD rs773609716, REVEL 0.13, CADD 16.70
- P22L (p.Pro22Leu), ExAC rs770120964, TOPMed rs770120964, gnomAD rs770120964, REVEL 0.10, CADD 22.60
- P22R (p.Pro22Arg), ExAC rs770120964, TOPMed rs770120964, gnomAD rs770120964, REVEL 0.09, CADD 19.90
- V24A (p.Val24Ala), Ensembl rs1596884823, REVEL 0.13, CADD 15.60
- V24G (p.Val24Gly), Ensembl rs1596884823, REVEL 0.21, CADD 18.90
- V24I (p.Val24Ile), Ensembl rs2073035329, REVEL 0.14, CADD 16.50
- V24S (p.Val24Ser), rs1338865633, NCI-TCGA Cosmic COSV5377, Variant assessed as somatic; high impact.
- P25L (p.Pro25Leu), TOPMed rs2073035221, REVEL 0.13, CADD 19.90
- P25R (p.Pro25Arg), TOPMed rs2073035221, REVEL 0.12, CADD 18.90
- P25S (p.Pro25Ser), cosmic curated COSV53773, TOPMed rs1044163469, REVEL 0.15, CADD 10.70
- G26E (p.Gly26Glu), ExAC rs775053127, gnomAD rs775053127, REVEL 0.07, CADD 16.00
- G26V (p.Gly26Val), ExAC rs775053127, gnomAD rs775053127, REVEL 0.06, CADD 17.50
- E27D (p.Glu27Asp), gnomAD rs1372891365, REVEL 0.15, CADD 7.68
- E27G (p.Glu27Gly), cosmic curated COSV53771, Ensembl rs1596884789, REVEL 0.10, CADD 23.10
- E27K (p.Glu27Lys), gnomAD rs1302416785, REVEL 0.10, CADD 15.90
- V28G (p.Val28Gly), Ensembl rs868114863, REVEL 0.18, CADD 23.30
- E29G (p.Glu29Gly), TOPMed rs1336432605, REVEL 0.34, CADD 24.40
- M30R (p.Met30Arg), gnomAD rs1326850245
- M30T (p.Met30Thr), gnomAD rs1326850245
- M30V (p.Met30Val), TOPMed rs2073034798
- V31A (p.Val31Ala), ESP rs375146669, ExAC rs375146669, TOPMed rs375146669, gnomAD rs375146669, REVEL 0.32, CADD 23.10, Uncertain significance, not specified
- V31G (p.Val31Gly), ESP rs375146669, ExAC rs375146669, TOPMed rs375146669, gnomAD rs375146669, REVEL 0.43, CADD 23.70, Uncertain significance, not specified
- G33E (p.Gly33Glu), TOPMed rs1280565276
- G33W (p.Gly33Trp), cosmic curated COSV99532, gnomAD rs865801855, REVEL 0.57, CADD 27.30
- Q34* (p.Gln34Ter), TOPMed rs2073034611, gnomAD rs2073034611, CADD 36.00
- Q34H (p.Gln34His), TOPMed rs2073034563, REVEL 0.14, CADD 19.80
- P35S (p.Pro35Ser), cosmic curated COSV53772, Ensembl rs2151048720, REVEL 0.07, CADD 17.70
- D37E (p.Asp37Glu), TOPMed rs980128823, gnomAD rs980128823
- V38E (p.Val38Glu), Ensembl rs2151048709
- V38L (p.Val38Leu), rs1394035337, ClinGen CA395491483, ClinVar RCV004183027, TOPMed rs1394035337, REVEL 0.07, CADD 22.20, Uncertain significance, not specified
- V38M (p.Val38Met), cosmic curated COSV10730, TOPMed rs1394035337, gnomAD rs1394035337, REVEL 0.22, CADD 25.60, Uncertain significance
- G39A (p.Gly39Ala), gnomAD rs2073034354, REVEL 0.08, CADD 22.50
- G39C (p.Gly39Cys), gnomAD rs1173425325
- G39S (p.Gly39Ser), gnomAD rs1173425325
- P40L (p.Pro40Leu), ExAC rs755905535, TOPMed rs755905535, gnomAD rs755905535, REVEL 0.15, CADD 22.80, Uncertain significance, not specified
- P40Q (p.Pro40Gln), ExAC rs755905535, TOPMed rs755905535, gnomAD rs755905535, REVEL 0.16, CADD 22.60, Uncertain significance
- P40S (p.Pro40Ser), 1000Genomes rs555123973, ExAC rs555123973, gnomAD rs555123973, REVEL 0.13, CADD 21.60
- R41C (p.Arg41Cys), Ensembl rs868133732
- R41H (p.Arg41His), gnomAD rs1437705688, REVEL 0.24, CADD 23.00
- R41L (p.Arg41Leu), gnomAD rs1437705688, REVEL 0.28, CADD 24.20
- Y42* (p.Tyr42Ter), rs1197559363, ClinGen CA395491404, ClinVar RCV003402313, Uncertain significance
- Y42C (p.Tyr42Cys), ExAC rs752945713, gnomAD rs752945713, REVEL 0.62, CADD 29.30
- T43M (p.Thr43Met), ExAC rs781519812, TOPMed rs781519812, gnomAD rs781519812, REVEL 0.05, CADD 22.50
- T43R (p.Thr43Arg), ExAC rs781519812, TOPMed rs781519812, gnomAD rs781519812, REVEL 0.31, CADD 20.70
- Q44* (p.Gln44Ter), ExAC rs755251449, gnomAD rs755251449, CADD 36.00
- L45F (p.Leu45Phe), ExAC rs751628704, gnomAD rs751628704, REVEL 0.11, CADD 19.90
- Q46H (p.Gln46His), NCI-TCGA Cosmic COSV9953, cosmic curated COSV99531, Variant assessed as somatic; moderate impact.
- Y47* (p.Tyr47Ter), gnomAD rs971370284, CADD 36.00
- I48M (p.Ile48Met), Ensembl rs2151048657
- I48T (p.Ile48Thr), ExAC rs766621106, gnomAD rs766621106, REVEL 0.49, CADD 27.10
- I48V (p.Ile48Val), gnomAD rs2073033788, REVEL 0.05, CADD 21.00
- E50* (p.Glu50Ter), TOPMed rs2073033657, gnomAD rs2073033657, CADD 36.00
- E50Q (p.Glu50Gln), TOPMed rs2073033657, gnomAD rs2073033657, REVEL 0.08, CADD 22.50
- A52T (p.Ala52Thr), Ensembl rs2151048642, REVEL 0.33, CADD 26.20
- Y53* (p.Tyr53Ter), TOPMed rs1374312265, gnomAD rs1374312265, CADD 35.00
- Y53C (p.Tyr53Cys), cosmic curated COSV99531, Ensembl rs2151048638, REVEL 0.27, CADD 27.60
- G54C (p.Gly54Cys), rs1313150757, NCI-TCGA Cosmic COSV9953, cosmic curated COSV99531, gnomAD rs1313150757, REVEL 0.43, CADD 28.10, Variant assessed as somatic; moderate impact.
- G54D (p.Gly54Asp), Ensembl rs2151048629, REVEL 0.56, CADD 25.20
- G54S (p.Gly54Ser), gnomAD rs1313150757, REVEL 0.42, CADD 27.00
- M55L (p.Met55Leu), ExAC rs762034287, gnomAD rs762034287, REVEL 0.08, CADD 22.60
- M55R (p.Met55Arg), gnomAD rs889768664, REVEL 0.40, CADD 25.60, Uncertain significance
- M55T (p.Met55Thr), rs889768664, ClinGen CA280416299, ClinVar RCV002247964, gnomAD rs889768664, REVEL 0.31, CADD 22.90, Uncertain significance, not specified
- V56D (p.Val56Asp), gnomAD rs1157149769
- V56G (p.Val56Gly), gnomAD rs1157149769, REVEL 0.89, CADD 28.90
- V56I (p.Val56Ile), Ensembl rs1024996900, REVEL 0.41, CADD 25.20
- S58* (p.Ser58Ter), rs1370684329, gnomAD rs1370684329, AlphaMissense 0.68, MetaLR 0.24, Variant assessed as somatic; high impact.
- S58L (p.Ser58Leu), NCI-TCGA TCGA novel, gnomAD rs1370684329, REVEL 0.50, AlphaMissense 0.68, Variant assessed as somatic; moderate impact.
- Y60C (p.Tyr60Cys), cosmic curated COSV10808, 1000Genomes rs147961867, ESP rs147961867, ExAC rs147961867, REVEL 0.13, CADD 23.40
- Y60H (p.Tyr60His), Ensembl rs2151047916
- V63M (p.Val63Met), cosmic curated COSV53771, 1000Genomes rs200617125, ESP rs200617125, ExAC rs200617125, REVEL 0.08, CADD 21.80
- R64C (p.Arg64Cys), cosmic curated COSV53772, ExAC rs753070820, TOPMed rs753070820, gnomAD rs753070820, REVEL 0.13, CADD 26.50
- R64G (p.Arg64Gly), ExAC rs753070820, TOPMed rs753070820, gnomAD rs753070820, REVEL 0.13, CADD 25.40
- R64H (p.Arg64His), TOPMed rs1196812695, REVEL 0.08, CADD 23.70
- R64L (p.Arg64Leu), NCI-TCGA Cosmic COSV9953, cosmic curated COSV99531, REVEL 0.08, CADD 23.60, Variant assessed as somatic; moderate impact.
- R64P (p.Arg64Pro), TOPMed rs1196812695
- T66N (p.Thr66Asn), TOPMed rs2073020790, REVEL 0.05, CADD 18.60
- T66S (p.Thr66Ser), TOPMed rs2073020790
- R67C (p.Arg67Cys), cosmic curated COSV53772, 1000Genomes rs567762331, ExAC rs567762331, TOPMed rs567762331, REVEL 0.60, CADD 28.80
- R67G (p.Arg67Gly), 1000Genomes rs567762331, ExAC rs567762331, TOPMed rs567762331, gnomAD rs567762331, REVEL 0.54, CADD 26.00
- R67H (p.Arg67His), ExAC rs772578869, TOPMed rs772578869, gnomAD rs772578869, REVEL 0.48, CADD 27.80
- R67L (p.Arg67Leu), ExAC rs772578869, TOPMed rs772578869, gnomAD rs772578869, REVEL 0.42, CADD 23.10
- R67S (p.Arg67Ser), 1000Genomes rs567762331, ExAC rs567762331, TOPMed rs567762331, gnomAD rs567762331, REVEL 0.45, CADD 25.90
- V68M (p.Val68Met), ExAC rs776770058, gnomAD rs776770058, REVEL 0.76, CADD 26.70
- A69D (p.Ala69Asp), ExAC rs768729666, TOPMed rs768729666, gnomAD rs768729666, REVEL 0.84, CADD 31.00
- A69T (p.Ala69Thr), Ensembl rs2151047890
- A69V (p.Ala69Val), ExAC rs768729666, TOPMed rs768729666, gnomAD rs768729666, REVEL 0.82, CADD 31.00
- I70M (p.Ile70Met), ExAC rs775457072, gnomAD rs775457072, REVEL 0.64, CADD 25.40
- I70V (p.Ile70Val), ExAC rs746736375, gnomAD rs746736375, REVEL 0.30, CADD 25.90
- K71E (p.Lys71Glu), Ensembl rs2151047883
- I73M (p.Ile73Met), NCI-TCGA Cosmic COSV5377, cosmic curated COSV53775, Variant assessed as somatic; moderate impact.
- S74N (p.Ser74Asn), gnomAD rs1483843681
- S74T (p.Ser74Thr), gnomAD rs1483843681
- P75L (p.Pro75Leu), gnomAD rs1277805136, REVEL 0.60, CADD 31.00
- F76L (p.Phe76Leu), ExAC rs772136444, TOPMed rs772136444, gnomAD rs772136444, REVEL 0.40, CADD 22.70
- E77D (p.Glu77Asp), ExAC rs771108532, gnomAD rs771108532, REVEL 0.20, CADD 15.70
- E77K (p.Glu77Lys), rs778826879, NCI-TCGA Cosmic COSV5377, cosmic curated COSV53772, ExAC rs778826879, REVEL 0.54, CADD 29.20, Uncertain significance
- E77Q (p.Glu77Gln), rs778826879, ClinGen CA8002908, ClinVar RCV004309401, ExAC rs778826879, REVEL 0.34, CADD 26.40, Uncertain significance, not specified
- H78Y (p.His78Tyr), ExAC rs749779624, TOPMed rs749779624, gnomAD rs749779624, REVEL 0.44, CADD 27.50
- Q79H (p.Gln79His), ExAC rs778192562, TOPMed rs778192562, gnomAD rs778192562, NCI-TCGA Cosmic COSV9953, REVEL 0.20, CADD 21.00, Variant assessed as somatic; moderate impact.
- T80P (p.Thr80Pro), Ensembl rs1596883447
- Y81H (p.Tyr81His), gnomAD rs1297705239, REVEL 0.48, CADD 24.60
- C82R (p.Cys82Arg), ExAC rs756613927, TOPMed rs756613927, gnomAD rs756613927, REVEL 0.69, CADD 30.00
- C82W (p.Cys82Trp), Ensembl rs2151047840
- C82Y (p.Cys82Tyr), NCI-TCGA Cosmic COSV9953, cosmic curated COSV99531, Variant assessed as somatic; moderate impact.
- R84C (p.Arg84Cys), ExAC rs781660515, gnomAD rs781660515, REVEL 0.72, CADD 32.00
- R84H (p.Arg84His), NCI-TCGA Cosmic COSV5377, cosmic curated COSV53774, ExAC rs757959447, gnomAD rs757959447, Variant assessed as somatic; moderate impact.
- R84L (p.Arg84Leu), ExAC rs757959447, gnomAD rs757959447, REVEL 0.79, CADD 29.50
- T85K (p.Thr85Lys), TOPMed rs1375850297, gnomAD rs1375850297, REVEL 0.69, CADD 29.40
- T85M (p.Thr85Met), cosmic curated COSV10960, NCI-TCGA TCGA novel, TOPMed rs1375850297, gnomAD rs1375850297, REVEL 0.61, CADD 29.20, Variant assessed as somatic; moderate impact.
- R87G (p.Arg87Gly), ExAC rs750160678, gnomAD rs750160678
- R87Q (p.Arg87Gln), ESP rs374549766, ExAC rs374549766, TOPMed rs374549766, gnomAD rs374549766, REVEL 0.70, CADD 28.90
- R87W (p.Arg87Trp), rs750160678, NCI-TCGA Cosmic COSV5377, cosmic curated COSV53774, ExAC rs750160678, REVEL 0.74, CADD 26.10, Variant assessed as somatic; moderate impact.
- E88K (p.Glu88Lys), rs1315743155, TOPMed rs1315743155, gnomAD rs1315743155, REVEL 0.94, CADD 28.50, Variant assessed as somatic; moderate impact.
- I89V (p.Ile89Val), ESP rs141047495, ExAC rs141047495, TOPMed rs141047495, gnomAD rs141047495, REVEL 0.24, CADD 22.90
- I91F (p.Ile91Phe), gnomAD rs2073019201, REVEL 0.82, CADD 28.50
- I91M (p.Ile91Met), TOPMed rs1258517367
- L92V (p.Leu92Val), gnomAD rs1209777305, REVEL 0.54, CADD 22.90, Uncertain significance, not specified
- L93Q (p.Leu93Gln), ExAC rs760710625, gnomAD rs760710625, REVEL 0.42, CADD 23.10
- R94C (p.Arg94Cys), NCI-TCGA Cosmic COSV5377, cosmic curated COSV53772, Ensembl rs1596883362, Variant assessed as somatic; moderate impact.
- R94H (p.Arg94His), gnomAD rs1212630199
- R94L (p.Arg94Leu), gnomAD rs1212630199, REVEL 0.46, CADD 24.20
- F95V (p.Phe95Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R96C (p.Arg96Cys), NCI-TCGA Cosmic COSV9953, cosmic curated COSV99531, ExAC rs771940747, TOPMed rs771940747, REVEL 0.10, CADD 24.50, Variant assessed as somatic; moderate impact.
- R96G (p.Arg96Gly), ExAC rs771940747, TOPMed rs771940747, gnomAD rs771940747
- R96H (p.Arg96His), cosmic curated COSV53773, Ensembl rs2151047779, REVEL 0.01, CADD 19.30
- R96L (p.Arg96Leu), Ensembl rs2151047779
- H97L (p.His97Leu), gnomAD rs1229544781, REVEL 0.91, CADD 28.80
- E98K (p.Glu98Lys), NCI-TCGA Cosmic COSV5377, cosmic curated COSV53775, Ensembl rs2151047778, Variant assessed as somatic; moderate impact.
- V100I (p.Val100Ile), ExAC rs759671938, gnomAD rs759671938, REVEL 0.07, CADD 18.20
- G102D (p.Gly102Asp), NCI-TCGA Cosmic COSV5377, cosmic curated COSV53773, Variant assessed as somatic; moderate impact.
- G102R (p.Gly102Arg), TOPMed rs1291454132, gnomAD rs1291454132, REVEL 0.23, CADD 22.80
Public MAPK3 analysis runs
- MAPK3 analysis run — MAPK3 (729 variants) — completed 2026-08-19